Author:
Pal Sumanta Kumar,Figlin Robert A.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Oncology
Reference113 articles.
1. The Pharma Letter (1992, May) Available at: http://www.thepharmaletter.com/file/45036/chirons-il-2-approved-in-usa.html ; last accessed December 2, 2010
2. Fyfe G, Fisher RI, Rosenberg SA, Sznol M, Parkinson DR, Louie AC (1995) Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy. J Clin Oncol 13(3):688–696
3. Motzer RJ, Bacik J, Murphy BA, Russo P, Mazumdar M (2002) Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma. J Clin Oncol 20(1):289–296. doi: 10.1200/jco.20.1.289
4. FDA Approval Letter for Sorafenib. Available at: http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/021923ltr.pdf ; last accessed March 24, 2010
5. FDA Approval Letter for Sunitinib. Available at http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/021968s000ltr.pdf ; last accessed March 24, 2010
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献